Cargando…

Survival analysis and prognostic factors of the carcinoma of gallbladder

BACKGROUND: The present study aims to evaluate the survival status of patients with gallbladder cancer (GBC) and explore the prognostic factors for the improvement and preventions. METHODS: The study consists of 176 patients with clinically diagnosed gallbladder cancer; the study was conducted betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Feroz, Zainab, Gautam, Priyanka, Tiwari, Sonia, Shukla, Girish C., Kumar, Munish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764491/
https://www.ncbi.nlm.nih.gov/pubmed/36539838
http://dx.doi.org/10.1186/s12957-022-02857-y
_version_ 1784853283164127232
author Feroz, Zainab
Gautam, Priyanka
Tiwari, Sonia
Shukla, Girish C.
Kumar, Munish
author_facet Feroz, Zainab
Gautam, Priyanka
Tiwari, Sonia
Shukla, Girish C.
Kumar, Munish
author_sort Feroz, Zainab
collection PubMed
description BACKGROUND: The present study aims to evaluate the survival status of patients with gallbladder cancer (GBC) and explore the prognostic factors for the improvement and preventions. METHODS: The study consists of 176 patients with clinically diagnosed gallbladder cancer; the study was conducted between 2019 and 2021 registered at Kamala Nehru Memorial Cancer Hospital, Prayagraj, India. The survival rates were analyzed by the Kaplan-Meier method; survival rate difference was analyzed by log-rank test, prognosis factors; and hazard ratio for mortality outcomes was estimated using Cox regression method. RESULTS: The overall median survival time of patients was 5 months with the 1-year, 2-year, and 3-year survival rates of 24.4%, 8.5%, and 4.5%, respectively. The 3-year survival for patients with jaundice was 2.9%, liver infiltration (4.2%), gallstones (0.8%), and with advanced tumor grade (1.4%). Elderly GBC patients had lower survival rates (3.8%), while the 3-year overall survival for patients residing in urban areas dropped to zero. No patients in the tumor stage (T3/T4) and with distance metastasis stage survived in 3 years, while only 1.1% of patients with advanced nodal stage survived. On receiving surgery and radiation therapy, the 3-year survival rate increased to 19.5% and 35%, respectively. The results of multivariate analysis showed that urban region (HR = 1.568, p = 0.040), gallstone or not (1.571, p = 0.049), N stage (HR = 1.468, p = 0.029), and M stage (HR = 2.289, p < 0.0001) were independent risk factors for prognosis, while surgery or not (HR = 0.573, p = 0.030) was the protective factor for the prognosis of GBC. CONCLUSION: The overall survival of GBC in the Gangetic belt is poor. The geographical region of patients, gallstones, and N and M stage was the risk factors for prognosis, while surgery or not was the protective factor for the prognosis of GBC.
format Online
Article
Text
id pubmed-9764491
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97644912022-12-21 Survival analysis and prognostic factors of the carcinoma of gallbladder Feroz, Zainab Gautam, Priyanka Tiwari, Sonia Shukla, Girish C. Kumar, Munish World J Surg Oncol Research BACKGROUND: The present study aims to evaluate the survival status of patients with gallbladder cancer (GBC) and explore the prognostic factors for the improvement and preventions. METHODS: The study consists of 176 patients with clinically diagnosed gallbladder cancer; the study was conducted between 2019 and 2021 registered at Kamala Nehru Memorial Cancer Hospital, Prayagraj, India. The survival rates were analyzed by the Kaplan-Meier method; survival rate difference was analyzed by log-rank test, prognosis factors; and hazard ratio for mortality outcomes was estimated using Cox regression method. RESULTS: The overall median survival time of patients was 5 months with the 1-year, 2-year, and 3-year survival rates of 24.4%, 8.5%, and 4.5%, respectively. The 3-year survival for patients with jaundice was 2.9%, liver infiltration (4.2%), gallstones (0.8%), and with advanced tumor grade (1.4%). Elderly GBC patients had lower survival rates (3.8%), while the 3-year overall survival for patients residing in urban areas dropped to zero. No patients in the tumor stage (T3/T4) and with distance metastasis stage survived in 3 years, while only 1.1% of patients with advanced nodal stage survived. On receiving surgery and radiation therapy, the 3-year survival rate increased to 19.5% and 35%, respectively. The results of multivariate analysis showed that urban region (HR = 1.568, p = 0.040), gallstone or not (1.571, p = 0.049), N stage (HR = 1.468, p = 0.029), and M stage (HR = 2.289, p < 0.0001) were independent risk factors for prognosis, while surgery or not (HR = 0.573, p = 0.030) was the protective factor for the prognosis of GBC. CONCLUSION: The overall survival of GBC in the Gangetic belt is poor. The geographical region of patients, gallstones, and N and M stage was the risk factors for prognosis, while surgery or not was the protective factor for the prognosis of GBC. BioMed Central 2022-12-20 /pmc/articles/PMC9764491/ /pubmed/36539838 http://dx.doi.org/10.1186/s12957-022-02857-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Feroz, Zainab
Gautam, Priyanka
Tiwari, Sonia
Shukla, Girish C.
Kumar, Munish
Survival analysis and prognostic factors of the carcinoma of gallbladder
title Survival analysis and prognostic factors of the carcinoma of gallbladder
title_full Survival analysis and prognostic factors of the carcinoma of gallbladder
title_fullStr Survival analysis and prognostic factors of the carcinoma of gallbladder
title_full_unstemmed Survival analysis and prognostic factors of the carcinoma of gallbladder
title_short Survival analysis and prognostic factors of the carcinoma of gallbladder
title_sort survival analysis and prognostic factors of the carcinoma of gallbladder
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764491/
https://www.ncbi.nlm.nih.gov/pubmed/36539838
http://dx.doi.org/10.1186/s12957-022-02857-y
work_keys_str_mv AT ferozzainab survivalanalysisandprognosticfactorsofthecarcinomaofgallbladder
AT gautampriyanka survivalanalysisandprognosticfactorsofthecarcinomaofgallbladder
AT tiwarisonia survivalanalysisandprognosticfactorsofthecarcinomaofgallbladder
AT shuklagirishc survivalanalysisandprognosticfactorsofthecarcinomaofgallbladder
AT kumarmunish survivalanalysisandprognosticfactorsofthecarcinomaofgallbladder